Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ceci, A
Right arrow Articles by Maggio, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ceci, A
Right arrow Articles by Maggio, A
Haematologica, Vol 91, Issue 10, 1420-1421
Copyright © 2006 by Ferrata Storti Foundation

Clinical Trial

Risk factors for death in patients with beta-thalassemia major: results of a case-control study

A Ceci, P Baiardi, M Catapano, M Felisi, P Cianciulli, V De Sanctis, GC Del Vecchio, C Magnano, A Meo, and A Maggio

This retrospective one to one matched case-control study was aimed at evaluating risk factors for death in beta-thalassemic patients followed in Italian centers between 1997 and 2001. The mortality risk was lower in patients with good compliance to iron chelation therapy and in those treated with deferiprone.


This article has been cited by other articles:


Home page
 haematolHome page
E. Angelucci, G. Barosi, C. Camaschella, M. D. Cappellini, M. Cazzola, R. Galanello, M. Marchetti, A. Piga, and S. Tura
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
Haematologica, May 1, 2008; 93(5): 741 - 752.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2006 by the Ferrata Storti Foundation.